BackSage Therapeutics Overview

Sage Therapeutics Other Current Assets

Track Sage Therapeutics's other current assets ($44M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Other Current Assets
$43.51M
↑ 8.73% YoYΔ $3.50M vs prior year quarter

Peer average

Loading

Sage Therapeutics Other Current Assets History

Loading

Sage Therapeutics vs. peers: Other Current Assets Comparison

Loading

Sage Therapeutics Other Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Sage Therapeutics (SAGE) FAQ

As of the most recent data (June 2025), SAGE shows a other current assets of $44M. That compares with $40M in the prior-year period — up 8.7% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, SAGE's other current assets is now $44M (was $40M) — a 8.7% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Sage Therapeutics is outperforming or lagging.

Tracking SAGE's other current assets over time shows whether Sage Therapeutics is scaling, shrinking, or reshaping that part of the business. The current reading is $44M That compares with $40M in the prior-year period — up 8.7% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this other current assets page, Stockcircle has Sage Therapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect other current assets (currently $44M) with ownership activity and broader fundamentals.

Sage Therapeutics's other current assets is $44M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.